InvestorsHub Logo
Followers 2
Posts 1855
Boards Moderated 0
Alias Born 06/30/2014

Re: 66Mustang post# 54815

Wednesday, 05/31/2017 1:03:03 PM

Wednesday, May 31, 2017 1:03:03 PM

Post# of 140475
I don't think it's as much about distrust (for me at least) as it is the reality that we have a long and hard road still ahead, with high risks of losing it all. We all thought we'd be at market by 2017. We all know what transpired, no need to re-hash what has already been hashed to death.

The reality setting in for me is (and I hope I'm completely wrong) is this is a dead investment until 2020 with a high risk of losing it all a long the way. Especially if there is another delay in milestones. We aren't far enough along for legitimate partnership/buyout opportunities. Yet sit here at .25/share operating "paycheck to paycheck". Not to mention other companies possibly entering the market in 2019 while we're still in the FDA approval process. And that's if we don't have any delays. A LOT has to go exactly right just to be in the market in basically 2 1/2 to 3 years. Not very encouraging to say the least.


I do find the lack of information a bit disturbing, but I don't have any evidence that the new management team is lying to us. There seems to be a rapidly growing distrust here on the message board, as well as a diminished outlook, despite no real change to drive those viewpoints downward. Particularly with AGM so close, we should not be expecting any sort of announcement unless some huge breakthrough happens to hit between now and then, and this is a bit premature for that type of a breakthrough. The sole exception I can think of is something which resolves our imminent funding issue. Not likely in the next two weeks.